Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines
Open Access
- 20 October 2025
- journal article
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (20) , 5347-5349
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patientsBlood Advances, 2025
- What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future?Research and Practice in Thrombosis and Haemostasis, 2023
- Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trialThe Lancet Haematology, 2021
- Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialThe Lancet Haematology, 2020
- Changing landscape of anticoagulation therapy in childrenThe Lancet Haematology, 2019
- Improving healthcare quality in Europe: Characteristics, effectiveness and implementation of different strategies2019
- American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolismBlood Advances, 2018
- Management of Venous Thromboembolism: A Systematic Review for a Practice GuidelineAnnals of Internal Medicine, 2007